The Cambridge biotechnology company Momenta Pharmaceuticals Inc. may still be years away from having a product on the market, but its experimental drug has just triggered a legal battle between two global pharmaceutical giants.>>> Discuss This Story
The Cambridge biotechnology company Momenta Pharmaceuticals Inc. may still be years away from having a product on the market, but its experimental drug has just triggered a legal battle between two global pharmaceutical giants.>>> Discuss This Story